April 19, 2017
Forward Pharma reports $33M net loss
Forward Pharma has reported financial results for the year ended December 31, 2016.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Forward Pharma
March 1, 2017
Forward Pharma puts new CEO to reduce burn rate after $1.25 billion settlement with Biogen
Board of Directors has appointed its former executive vice preisdent Claus Bo Svendsen, as Chief Executive Officer, as it plans to pursue important objectives related to the the Settlement and License Agreement with Biogen.
February 9, 2017
Forward Pharma cashes in Biogen’s $1.25 billion
Forward Pharma has received $ 1.25 billion due to the settlement with Biogen’s subsidiaries, it made in January.
January 17, 2017
Biogen settles to pay Danish Forward $1.25 bilion
Danish biopharmaceutical company, Forward Pharma, has entered a deal with Biogen and certain other parties, regarding a Settlement and License Agreement.